89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384 | -16.3% | 24,851 | +2.7% | 0.00% | 0.0% |
| Q2 2023 | $459 | – | 24,200 | +28039.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 86 | -98.9% | 0.00% | – |
| Q1 2022 | $31,000 | -71.0% | 8,186 | +0.1% | 0.00% | – |
| Q4 2021 | $107,000 | -33.5% | 8,181 | -0.2% | 0.00% | – |
| Q3 2021 | $161,000 | +5.2% | 8,196 | +0.4% | 0.00% | – |
| Q2 2021 | $153,000 | -20.3% | 8,166 | +0.8% | 0.00% | – |
| Q1 2021 | $192,000 | -2.5% | 8,100 | 0.0% | 0.00% | – |
| Q4 2020 | $197,000 | +97.0% | 8,100 | +107.7% | 0.00% | – |
| Q3 2020 | $100,000 | +28.2% | 3,900 | 0.0% | 0.00% | – |
| Q2 2020 | $78,000 | -20.4% | 3,900 | 0.0% | 0.00% | – |
| Q1 2020 | $98,000 | -4.9% | 3,900 | 0.0% | 0.00% | – |
| Q4 2019 | $103,000 | – | 3,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |